Skip to content

Detection of Malignant Tumors with Radiopharmaceutical Tc-99m FAPI and SPECT imaging

Detection of Malignant Tumors with Radiopharmaceutical Tc-99m FAPI and SPECT imaging

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240626062262N1
Enrollment
20
Registered
2024-07-04
Start date
2024-08-21
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant neoplasm. Malignant neoplasm

Interventions

Intervention group: Intervention group: The majority of epithelial tumors recruit fibroblasts and other non-malignant cells and activate them into cancer-associated fibroblasts. This often leads to ov

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Volunteering to participate in clinical trials and signing an informed consent form (signed by participant, parent, or legal representative) Patients with suspected or new diagnosed or previously treated malignant tumors Inconclusive findings on imaging modalities.

Exclusion criteria

Exclusion criteria: Pregnant and lactating women The inability or unwillingness of the research participant, parent, or legal representative to provide written informed consent

Design outcomes

Primary

MeasureTime frame
Target/Background ratio of 99mTc-FAPI SPECT/CT in Diagnosis of malignancies. Timepoint: 99mTc-FAPI Imaging at 1and 4 hours after the administration of the Radiotracer. Method of measurement: SPECT/CT scanner.

Secondary

MeasureTime frame
Target/Background ratio of 99mTc-FAPI SPECT/CT in Diagnosis of malignancies. Timepoint: 99mTc-FAPI Imaging at 1and 4 hours after the administration of the Radiotracer. Method of measurement: SPECT/CT scanner.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEsmaeil Gharepapagh

Tabriz University of Medical Sciences

esmaeil.gharepapagh@gmail.com+98 41 3336 2504

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026